Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

@article{Hanna2013TrendsAD,
  title={Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.},
  author={David B. Hanna and Kate Buchacz and Kelly A. Gebo and Nancy A. Hessol and Michael A Horberg and Lisa Paula Jacobson and Gregory D Kirk and Mari M. Kitahata and Philip Todd Korthuis and Richard Moore and Sonia Napravnik and Pragna Patel and M J Silverberg and Timothy R. Sterling and James H. Willig and Bryan Lau and Keri N. Althoff and Heidi M. Crane and Ann C Collier and H Samji and Jennifer E. Thorne and Michael J. Gill and Marina B Klein and Jeffrey N Martin and Benigno Rodr{\'i}guez and Sean B Rourke and Stephen J Gange},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2013},
  volume={56 8},
  pages={1174-82}
}
BACKGROUND Since the mid-1990s, effective antiretroviral therapy (ART) regimens have improved in potency, tolerability, ease of use, and class diversity. We sought to examine trends in treatment initiation and resulting human immunodeficiency virus (HIV) virologic suppression in North America between 2001 and 2009, and demographic and geographic disparities in these outcomes. METHODS We analyzed data on HIV-infected individuals newly clinically eligible for ART (ie, first reported CD4+ count… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 18 times over the past 90 days. VIEW TWEETS
32 Citations
42 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Similar Papers

Loading similar papers…